SPMC Q4 2026 Earnings Call Transcript

Sound Point Meridian Capital reported Q4 net investment income of $7 million, or $0.34 per share, but this remained below the $0.75 per share distribution, while GAAP net loss totaled $74.7 million and NAV fell to $9.63 from $14.02. The portfolio recorded $4.1 million in realized losses and $77.6 million in unrealized losses, driven by CLO equity markdowns and weakness in software-exposed loans amid AI-related disruption. Management is rotating toward higher-yielding secondary CLO equity opportunities and says April NAV improved to $10.57 as loan prices and liability spreads tightened.

Analysis

SPMC is less a “yield story” today than a volatile convexity story: the quarter exposed how quickly CLO equity NAV can gap when loan marks, default assumptions, and liability spreads all move against the same portfolio at once. The key second-order effect is that the market is now paying the price for a forced de-risking cycle, which can be good for survivors: selling impaired equity at depressed marks can reset the portfolio toward higher forward IRR even if near-term GAAP looks ugly. That makes the current print more relevant as a setup for future cash-flow recovery than as a clean read on sustainable earnings power.

The biggest winner from this reset is secondary CLO equity buyers with disciplined underwriting and liquidity, because primary issuance still looks weak while refinancing optionality is re-opening. If liability spreads keep tightening for another 1-2 months, managers who preserved shorter non-call structures should see the fastest rebound in distributable cash flows; that mechanically favors equity holders able to refinance/liquidate earlier than the market expects. The loser set is any CLO equity book concentrated in software-adjacent loans, but the deeper issue is manager dispersion: this environment widens the gap between managers who can trade around AI disruption and those who cannot.

The contrarian read is that the worst may already be priced if loan prices and liability costs remain near current levels into June. April’s NAV rebound suggests the market is treating the February-March shock as a dislocation, not a regime break, and that can trigger a sharp mean reversion in CLO equity marks. The risk is that the rebound is fragile: if M&A issuance stalls again or AI fear broadens beyond software into services/health care, discount rates can re-widen quickly and erase the April recovery within a single quarter.

Key Decisions for Investors

• Long SPMC on weakness only if it trades at a material discount to reported NAV: the setup is asymmetric if April/May mark recovery persists, but downside is renewed NAV compression if spreads re-widen. Use a 3-6 month horizon and size modestly because earnings remain below the payout.
• Pair trade: long diversified, actively managed BDCs or structured-credit vehicles with stronger balance sheets versus short SPMC into any rally. The thesis is that capital preservation and refinancing flexibility should outperform in a market where CLO equity marks remain unstable.
• Sell downside via put spreads on SPMC for the next earnings window: the near-term catalyst path is binary, but the market is already signaling a fragile recovery. Favor 2-3 month maturities with strikes around pre-announcement trading ranges to monetize volatility decay.
• Long higher-quality loan managers / CLO equity secondary opportunities rather than primary issuance beneficiaries. The cleanest trade is to own vehicles exposed to secondary pricing dislocations and tighter liability spreads, where forward IRR can improve without needing fresh primary market demand.
• If credit weakens again, rotate into shorts on AI-sensitive loan proxies rather than SPMC itself. SPMC’s portfolio is already being rebalanced; the larger beta is in the underlying stressed software/AI-exposed credits that can reprice 10-20 points on sentiment shifts.